Opus Regulatory — Washington, DC | October 20 We'll be at Opus Regulatory's Global Labeling and Regulatory Symposium in Washington, DC. Come find our team to discuss how LexisNexis supports...
Regulatory Affairs Professionals Society — Charlotte, North Carolina | September 15–17 Meet us at RAPS Convergence 2026 in Charlotte — the flagship event for regulatory affairs professionals...
Informa Connect — Berlin, Germany | June 15–18 Find us at the MedTech Summit in Berlin, where regulatory affairs professionals and industry leaders tackle MDR/IVDR compliance and market access...
Drug Information Association — Philadelphia, Pennsylvania | June 14–18 We'll be at the DIA Global Annual Meeting in Philadelphia among thousands of life sciences professionals. Visit...
Drug Information Association — North Bethesda, Maryland | February 2–4 Join us at the DIA RSIDM Forum in North Bethesda. Connect with our team to see how LexisNexis helps life sciences organizations...
Our team captured what mattered most—AU-specific interpretations, common reviewer questions, and practical steps to de-risk your next submission.
Australia’s market is attractive—but only if you navigate TGA requirements with confidence. Fresh from the Australia Regulatory Device Summit, our attendees distilled the most useful, Australia-specific regulatory insights: how expectations are shifting, where submissions stall, and what quality evidence stands up best. Watch the recap video to learn more.